Awareness of the Saudi community toward multiple sclerosis in Al-Madinah Al- Munawarrah, Saudi Arabia


  • Zayed Alnefaie Department of Anatomy and Embryology, Al-Rayan Colleges, Al-Madinah Al-Munawwara, Saudi Arabia
  • Ghudai Hatem Alamri College of Medicine, Al-Rayan Colleges, Al-Madinah Al-Munawwara, Saudi Arabia
  • Ghadi Bassam Aljarboua College of Medicine, Al-Rayan Colleges, Al-Madinah Al-Munawwara, Saudi Arabia
  • Fatimah Mohammed Alnakhli College of Medicine, Al-Rayan Colleges, Al-Madinah Al-Munawwara, Saudi Arabia
  • Jana Jamil Abubaker College of Medicine, Al-Rayan Colleges, Al-Madinah Al-Munawwara, Saudi Arabia
  • Lajeen Faisal Alhazmi College of Medicine, Al-Rayan Colleges, Al-Madinah Al-Munawwara, Saudi Arabia
  • Rajaa M-Measar Alsadi College of Medicine, Al-Rayan Colleges, Al-Madinah Al-Munawwara, Saudi Arabia



KSA, MS, Awareness, Risk factors, Management


Background: Multiple sclerosis (MS) is an inflammatory neurodegenerative disease affecting the central nervous system (CNS); pathophysiological concepts revealed that exposure to some infectious agents during childhood and genetics involvement played a role. Data reported that females were more affected by MS than males due to genetic predisposition. Recent epidemiological data indicated a higher prevalence of MS in the Arabian Gulf region, with increasing incidence in the Kingdom of Saudi Arabia (KSA). Knowledge about MS shall aid in better management, diagnosis and treatment. This study aimed to assess the level of awareness about MS among participants in Al Madinah Al Munawarrah, KSA.

Methods: This was a cross-sectional non-interventional observational survey questionnaire among 381 participants in Al Madinah.

Results: The majority of participants were female aged more than 20 years old and high graded; 66.4% of the participants reported good awareness about MS, and 68% reported that MS impact the central nervous system, causing more illness among females aged between 20-39 years. Regarding the risk factors towards MS, Family history of MS and personal history of autoimmune diseases were on top of the list among the participants in relation to risk factors MS, with 43.3% and 38.1%, respectively.

Conclusions: In summary, our study shed light on the lack of knowledge about MS among the adult population in Al Madinah AL Munawarrah, KSA. A better understanding of MS shall contribute towards better diagnosing and management.


Justiz AA, Jan A. Physiology, Immune Response. StatPearls Publishing; 2019. Available at: books/NBK539801/. Accessed 05 May 2023.

Chen J-Q, Szodoray P, Zeher M. Toll-Like Receptor Pathways in Autoimmune Diseases. Clinical Reviews in Allergy & Immunology. 2016;50(1):1.

Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia A-S, McNamara JO, et al. The Subdivisions of the Central Nervous System. Neuroscience 2nd edition 2001; Available at: Accessed 05 May 2023.

Noyes K, Weinstock-Guttman B. Impact of diagnosis and early treatment on the course of multiple sclerosis. The American Journal of Managed Care. 2013;19(17 Suppl):s321-31.

Tafti D, Ehsan M, Xixis KL. Multiple Sclerosis. Treasure Island (FL): StatPearls Publishing; 2020. Available at: https://pubmed.ncbi.nlm.nih. gov/29763024/. Accessed 05 May 2023.

Multiple sclerosis statistics 2022. The Checkup. 2022. Available at: blog/news/multiple-sclerosis-statistics/. Accessed 05 May 2023.

NHS Choices. Causes - Multiple sclerosis. NHS. 2019. Available at: conditions/multiple-sclerosis/causes/. Accessed 05 May 2023.

Mayo Clinic. Multiple sclerosis - Symptoms and causes. Mayo Clinic. 2020. Available at: causes/syc-20350269. Accessed 05 May 2023.

Ghasemi N, Razavi S, Nikzad E. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell journal. 2017;19(1):1–10.

Bohlega S, Inshasi J, Tahan AR, Madani AB, Qahtani H, Rieckmann P. Multiple sclerosis in the Arabian Gulf countries: a consensus statement. Journal of Neurology. 2013;260(12):2959–63.

Al-Jumah M, Bunyan R, Otaibi HA, Cupler E, Ishak S, Shami S, et al. The Saudi Arabian National Multiple Sclerosis Registry (NMSR): Initial Results Saudi MS Registry Study Group* (P2.390). Neurology. 2018;90(15 Supplement).

AlJumah M, Bunyan R, Al Otaibi H, Al Towaijri G, Karim A, Al Malik Y, et al. Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study. BMC Neurology. 2020 Feb 8;20(1).

Stenager E. A global perspective on the burden of multiple sclerosis. The Lancet Neurology. 2019 Mar;18(3):227–8.

Bebo B, Cintina I, LaRocca N, Ritter L, Talente B, Hartung D, et al. The Economic Burden of Multiple Sclerosis in the United States. Neurology. 2022;98(18):e1810–7.

Patrick S, Connick P. Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review. Montazeri A, editor. PLOS ONE. 2019;14(2):e0197943.

Algahtani H, Almarri AK, Alharbi JH, Aljahdali MR, Haimed RA, Hariri R. Multiple Sclerosis in Saudi Arabia: Clinical, Social, and Psychological Aspects of the Disease. Cureus. 2021.

Aljumah M, Alroughani R, Alsharoqi I, Bohlega SA, Dahdaleh M, Deleu D, et al. Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries. Multiple Sclerosis International. 2013;2013:1–6.

World Health Organization, Federation MSI. Atlas : multiple sclerosis resources in the world 2008. 2008 [cited 2022 Dec 18]. Available at: 10665/43968. Accessed 05 May 2023.

Hudaif HSA, Bwardi NA, Kojan S. Assessment of multiple sclerosis awareness and knowledge among the Saudi population in Riyadh City. Multiple Sclerosis and Related Disorders. 2014;3(6):758.

Amer M, AlZahrani W, AlZahrani A. International Journal of Advanced Research. 2016 [cited 2022. Available at: 14172/assessment-of-multiple-sclerosis- awareness:-knowledge-and-attitude-among-saudi-population-in-taif-city. Accessed 05 May 2023.

Alotaibi L, Alkhalifah B. Assessment of knowledge and attitude of radiographers towards radiation protection in al Qassim region, Saudi Arabia. International Journal of Medicine. 2019;7(1):1.

Atlas of MS 2013. Available at: ms-2013/. Accessed 05 May 2023.

Kampman MT, Steffensen LH, Mellgren SI, Jørgensen L. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomized controlled trial. Multiple sclerosis (Houndmills, Basingstoke, England). 2012;18(8):1144–51.




How to Cite

Alnefaie, Z., Alamri, G. H., Aljarboua, G. B., Alnakhli, F. M., Abubaker, J. J., Alhazmi, L. F., & Alsadi, R. M.-M. (2023). Awareness of the Saudi community toward multiple sclerosis in Al-Madinah Al- Munawarrah, Saudi Arabia. International Journal Of Community Medicine And Public Health, 10(7), 2321–2326.



Original Research Articles